Jan Van Bocxlaer
21 – 30 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
- Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study
- Development of a nanocrystalline Paclitaxel formulation for HIPEC treatment
- Analytical performance evaluation of four cartridge-type blood gas analyzers
- Hypervariable cytochrome P450 activity in children with severe hepatic dysfunction
- Flavonoid deactivation of excited state flavins: reaction monitoring by mass spectrometry
- 2011
- Pharmacokinetics of two formulations of omeprazole administered through a gastrostomy tube in patients with severe neurodevelopmental problems
- In vitro cytochrome P450 activity: development and validation of a sensitive high performance liquid chromatography–tandem mass spectrometry method for the quantification of six probe metabolites after derivatization with pyridine-3-sulfonyl chloride in an aqueous environment
- Human salivary cortisol, part I: development and full validation of an LC-MS/MS based method
- An evaluation of using population pharmacokinetic models to estimate pharmacodynamic parameters for propofol and bispectral index in children
- Bioavailability of hop-derived iso-α-acids and reduced derivatives